Skip to content

Clinical trials

Phase 3 Osteoporosis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Phase: Phase 3 Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20021
20042
20061
20072
20081
20121
20182
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Eli Lilly and Company2
Novartis Pharmaceuticals2
Azienda Policlinico Umberto I1
ETOP IBCSG Partners Foundation1
Istituto Auxologico Italiano1
Ligand Pharmaceuticals1
Nordic Bioscience A/S1
Pfizer1
Radius Health, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis14
Osteoporosis, Postmenopausal3
Bone Diseases, Metabolic2
Fractures, Bone2
Bone Diseases1
Breast Neoplasms1
Cystic Fibrosis1
Diabetes Mellitus, Type 21
Musculoskeletal Diseases1
Spinal Fractures1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.